Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

KV-PREDICT Diagnostic Device in Patients With Heart Failure

NCT: NCT07805213 · NOT_YET_RECRUITING

NCT IDNCT07805213
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2027-04
SponsorKardioVis S.r.l. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a pilot, single-center, non-invasive interventional study evaluating the performance of KV-PREDICT, an investigational diagnostic medical device (Class IIa, not CE-marked), in adult patients with heart failure. During a single scheduled outpatient visit, the device is placed externally on the chest, over clothing, and records a single-lead ECG together with cardiac mechanical vibration signals for about 10 seconds. The study assesses whether the device can acquire signals of adequate quality and reproducibility to allow extraction of mechanical and electromechanical cardiac parameters (such as systolic and diastolic time intervals and the amplitudes of mechanical vibrations corresponding to the heart sounds S1-S4). The study does not aim to support clinical decisions, does not change patient management, and does not evaluate the diagnostic or predictive performance of the device. About 120 patients across NYHA functional classes I-III and different left-ventricular function profiles will be enrolled. No direct clinical benefit to participants is expected; anticipated risks are minimal given the non-invasive, brief procedure.

Frequently Asked Questions

What is KV-PREDICT Diagnostic Device in Patients With Heart Failure?

KV-PREDICT Diagnostic Device in Patients With Heart Failure is a clinical trial registered under NCT07805213. Current status: NOT_YET_RECRUITING.

What is the status of NCT07805213?

The current status of NCT07805213 (KV-PREDICT Diagnostic Device in Patients With Heart Failure) is: NOT_YET_RECRUITING.

When did KV-PREDICT Diagnostic Device in Patients With Heart Failure start?

KV-PREDICT Diagnostic Device in Patients With Heart Failure started on 2026-09.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.